Similar articles

• E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.

  Oliveira C, Ferreira P, Nabais S, Campos L, Ferreira A, Cirnes L, Alves CC, Veiga I, Fragoso M, Regateiro F, Dias LM, Moreira H, Suriano G, Machado JC, Lopes C, Castedo S, Carneiro F, Seruca R. Oliveira C, et al. Eur J Cancer. 2004 Aug;40(12):1897-903. doi: 10.1016/j.ejca.2004.04.027. Eur J Cancer. 2004. PMID: 15288293
• Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.

  Fitzgerald RC, Caldas C. Fitzgerald RC, et al. Gut. 2004 Jun;53(6):775-8. doi: 10.1136/gut.2003.022061. Gut. 2004. PMID: 15138199 Free PMC article.
• Lack of association between CDH1 C-160A genetic polymorphism and gastric cancer risk among Asian population.

  Pan F, Tian J, Zhang Y, Pan Y. Pan F, et al. DNA Cell Biol. 2012 Mar;31(3):275-6; author reply 277-9. doi: 10.1089/dna.2011.1495. Epub 2011 Dec 5. DNA Cell Biol. 2012. PMID: 22142022 No abstract available.
• Genetics of gastric cancer: clinical implications.

  Scarpa A, Moore PS. Scarpa A, et al. Suppl Tumori. 2003 Sep-Oct;2(5):S10-3. Suppl Tumori. 2003. PMID: 12914381 Review. No abstract available.
• Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility.

  Gao L, Nieters A, Brenner H. Gao L, et al. Aliment Pharmacol Ther. 2008 Sep 1;28(5):565-73. doi: 10.1111/j.1365-2036.2008.03760.x. Epub 2008 Jun 9. Aliment Pharmacol Ther. 2008. PMID: 18544073 Review.